Community and Healthcare-Associated Infections Reduction Act of 2007

Community and Healthcare-Associated Infections Reduction Act of 2007 - Directs the Agency for Healthcare Research and Quality (AHRQ), in collaboration with the Centers for Disease Control and Prevention (CDC), to develop best-practices guidelines for internal infection control plans to prevent, detect, control, and treat community and healthcare-associated infections at hospitals.

Requires AHRQ to: (1) establish best practices with supporting justification, including the establishment of an infection control oversight committee; (2) collaborate with other agencies and organizations whose area of expertise is the identification, treatment, and prevention of infectious disease; (3) publish proposed guidelines; (4) provide for a comment period of not less than 90 days; and (5) establish final guidelines.

Directs the Administrator of the Centers for Medicare and Medicaid Services to: (1) consult best practices guidelines in evaluating hospitals' infection control plans as a condition of participation in the Medicare program; and (2) report to Congress on the feasibility of reducing healthcare-associated infection rates through a Quality Improvement Payment Program.

Requires: (1) hospitals to report information about community and healthcare-associated infections to the CDC National Healthcare Safety Network, which shall be used by the CDC to develop a national database of infection rates in hospitals; (2) the Director of the CDC to award grants to states to carry out public awareness campaigns; (3) the Director of the National Institutes of Health (NIH) to expand and intensify NIH programs regarding research and related activities concerning such infections; (4) the Secretary of Health and Human Services to establish an interagency working group on community and healthcare-associated infections; and (5) the Government Accountability Office (GAO) to report to Congress on this Act's impact.